Association of IL-6 polymorphisms with gastric cancer risk: Evidences from a meta-analysis

Cytokine

Volumn 59, Issue 1, 2012, Pages 176-183

  Junli, Wang ^a   Wenjun, He ^b   Jinxin, Liu ^b   Legen, Nong ^a   Yesheng, Wei ^a   Fenglian, Yang ^a  

^a YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^b No1 People's Hospital of Nanning   (China)

Author keywords

Gastric cancer; Interleukin 6; Meta analysis; Polymorphisms

Indexed keywords

ADENINE; CYTOSINE; GUANINE; INTERLEUKIN 6;

ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; GENETIC ASSOCIATION; HUMAN; IL 6 174 GENE; IL 6 572 GENE; IL 6 597 GENE; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH CANCER; TUMOR GENE;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-6; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84861661712     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.032     Document Type: Article

References (43)

1. Crew K.D., Neugut A.I. Epidemiology of gastric cancer. World J Gastroenterol 2006, 12:354-362.
2. Parkin D.M. International variation. Oncogene 2004, 23:6329-6340.
3. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993, 54:594-606.
4. Yamaoka Y., Kita M., Kodama T., Sawai N., Imanishi J. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 1996, 110:1744-1752.
5. Figueiredo C., Machado J.C., Pharoah P., Seruca R., Sousa S., Carvalho R., et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 2002, 94:1680-1687.
6. Basso D., Scrigner M., Toma A., Navaglia F., Di Mario F., Rugge M., et al. Helicobacter pylori infection enhances mucosal interleukin-1 beta, interleukin-6, and the soluble receptor of interleukin-2. Int J Clin Lab Res 1996, 26:207-210.
7. Terry C.F., Loukaci V., Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000, 275:18138-18144.
8. Sfrent-Cornateanu R., Mihai C., Balan S., Ionescu R., Moldoveanu E. The IL-6 promoter polymorphism is associated with disease activity and disability in systemic sclerosis. J Cell Mol Med 2006, 10:955-959.
9. Jingjin L., Zemin G., Xin M., Donghong W., Jianhua G., Jie Y., et al. Correlation between an interleukin-6-572C/G polymorphism and chronic periodontitis. Int J Periodontics Restorative Dent 2010, 30:301-305.
10. Wilkening S., Hemminki K., Rudnai P., Gurzau E., Koppova K., Kumar R., et al. Case-control study in basal cell carcinoma of the skin: single nucleotide polymorphisms in three interleukin promoters pre-analysed in pooled DNA. Br J Dermatol 2006, 155:1139-1144.
11. El-Omar E.M., Rabkin C.S., Gammon M.D., Vaughan T.L., Risch H.A., Schoenberg J.B., et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003, 124:1193-1201.
12. Hwang I.R., Hsu P.I., Peterson L.E., Gutierrez O., Kim J.G., Graham D.Y., et al. Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter 2003, 8:142-148.
13. Kamarainen O.P., Solovieva S., Vehmas T., Luoma K., Riihimaki H., Ala-Kokko L., et al. Common interleukin-6 promoter variants associate with the more severe forms of distal interphalangeal osteoarthritis. Arthritis Res Ther 2008, 10:R21.
14. Gatti L.L., Burbano R.R., Zambaldi-Tunes M., de-Labio R.W., de Assumpcao P.P., de Arruda Cardoso-Smith M., et al. Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma. Arch Med Res 2007, 38:551-555.
15. Xing P.X., Xiao D.J., Hu A.L., Gao W., Wang Y.S., Wang H.C. Relationship between tumor necrosis factor-α and interleukin-6 gene polymorphism and susceptibility to gastric cancer. J Shandong Univ Health Sci 2006, 44:949-953.
16. Yu J., Jia Y., Cheung K.F., Zeng Z., Tian L., Wang S., et al. Polymorphisms in interleukin-6-6331 influences the susceptibility of a Chinese population to gastric cancer. Cancer Invest 2011, 29:564-572.
17. Ntais C., Polycarpou A., Ioannidis J.P. Meta-analysis of the association of the cathepsin D Ala224Val gene polymorphism with the risk of Alzheimer's disease: a HuGE gene-disease association review. Am J Epidemiol 2004, 159:527-536.
18. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
19. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
20. Mantel N., Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
21. Zintzaras E., Rodopoulou P., Sakellaridis N. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of stroke: a HuGE gene-disease association review and meta-analysis. Am J Epidemiol 2009, 169:523-532.
22. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
23. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
24. Liao W.C., Lin J.T., Wu C.Y., Huang S.P., Lin M.T., Wu A.S., et al. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res 2008, 14:428-434.
25. Savage S.A., Abnet C.C., Haque K., Mark S.D., Qiao Y.L., Dong Z.W., et al. Polymorphisms in interleukin-2, -6, and -10 are not associated with gastric cardia or esophageal cancer in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 2004, 13:1547-1549.
26. Deans C., Rose-Zerilli M., Wigmore S., Ross J., Howell M., Jackson A., et al. Host cytokine genotype is related to adverse prognosis and systemic inflammation in gastro-oesophageal cancer. Ann Surg Oncol 2007, 14:329-339.
27. Zhao Y., Xiao Y., Gao F., Zhang X., Song F. Relativity research on the association between the interleukin-6 gene polymorphisms and risk of gastric cancer in Wuwei area of Gansu province. Clin J Med Officer 2010, 38:25-27.
28. Kang J.M., Kim N., Lee D.H., Park J.H., Lee M.K., Kim J.S., et al. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol 2009, 43:420-428.
29. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S., et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102:1369-1376.
30. Bennermo M., Held C., Stemme S., Ericsson C.G., Silveira A., Green F., et al. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases?. Clin Chem 2004, 50:2136-2140.
31. Zheng C., Huang D.R., Bergenbrant S., Sundblad A., Osterborg A., Bjorkholm M., et al. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 2000, 109:39-45.
32. Olomolaiye O., Wood N.A., Bidwell J.L. A novel NlaIII polymorphism in the human IL-6 promoter. Eur J Immunogenet 1998, 25:267.
33. Endler G., Marsik C., Joukhadar C., Marculescu R., Mayr F., Mannhalter C., et al. The interleukin-6 G(-174)C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans. Clin Chem 2004, 50:195-200.
34. Brull D.J., Montgomery H.E., Sanders J., Dhamrait S., Luong L., Rumley A., et al. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001, 21:1458-1463.
35. Jerrard-Dunne P., Sitzer M., Risley P., Buehler A., von Kegler S., Markus H.S. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 2004, 35:2438-2443.
36. Fedetz M., Matesanz F., Pascual M., Martin J., Fernandez O., Guerrero M., et al. The -174/-597 promoter polymorphisms in the interleukin-6 gene are not associated with susceptibility to multiple sclerosis. J Neurol Sci 2001, 190:69-72.
37. Zhai R., Liu G., Yang C., Huang C., Wu C., Christiani D.C. The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 2001, 11:699-701.
38. Gao S.P., Pan M., Chen C., Ge L.J., Jiang M.H., Luan H., et al. The G to A polymorphism at -597 of the interleukin-6 gene is extremely rare in southern Han Chinese. Cytokine 2011, 55:1-3.
39. Park B.L., Lee H.S., Kim Y.J., Kim J.Y., Jung J.H., Kim L.H., et al. Association between interleukin 6 promoter variants and chronic hepatitis B progression. Exp Mol Med 2003, 35:76-82.
40. Komatsu Y., Tai H., Galicia J.C., Shimada Y., Endo M., Akazawa K., et al. Interleukin-6 (IL-6)-373 A9T11 allele is associated with reduced susceptibility to chronic periodontitis in Japanese subjects and decreased serum IL-6 level. Tissue Antigens 2005, 65:110-114.
41. Leak T.S., Langefeld C.D., Keene K.L., Gallagher C.J., Lu L., Mychaleckyj J.C., et al. Chromosome 7p linkage and association study for diabetes related traits and type 2 diabetes in an African-American population enriched for nephropathy. BMC Med Genet 2010, 11:22.
42. Castro F.A., Haimila K., Sareneva I., Schmitt M., Lorenzo J., Kunkel N., et al. Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population - a candidate gene approach. Int J Cancer 2009, 125:1851-1858.
43. Nei M., Saitou N. Genetic relationship of human populations and ethnic differences in reaction to drugs and food. Prog Clin Biol Res 1986, 214:21-37.